{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T15:33:01Z","timestamp":1790782381378,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,2,8]],"date-time":"2020-02-08T00:00:00Z","timestamp":1581120000000},"content-version":"am","delay-in-days":403,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004324","name":"Astellas Pharma US","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004324","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007054","name":"Meso Scale Diagnostics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.bulcan.2018.08.016","type":"journal-article","created":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T19:37:50Z","timestamp":1547840270000},"page":"S52-S58","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"S","title":["Transfusion dans l\u2019autogreffe et l\u2019allogreffe de cellules souches h\u00e9matopo\u00ef\u00e9tiques chez l\u2019adulte et l\u2019enfant\u00a0: recommandations de la Soci\u00e9t\u00e9 francophone de greffe de moelle et de th\u00e9rapie cellulaire (SFGM-TC)"],"prefix":"10.1016","volume":"106","author":[{"given":"Christine","family":"Giraud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Baptiste","family":"Thibert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohan","family":"Desbrosses","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9n\u00e9dicte","family":"Debiol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2320-7269","authenticated-orcid":false,"given":"Tamim","family":"Alsuliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Bardiaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Garban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thi Ngoc Phuong","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Samsonova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Yakoub-Agha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9n\u00e9dicte","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bulcan.2018.08.016_bib0160","series-title":"Transfusion de globules rouges homologues\u00a0: produits indications alternatives en h\u00e9matologie et en oncologie","author":"HAS","year":"2014"},{"key":"10.1016\/j.bulcan.2018.08.016_bib0165","series-title":"Transfusion de plaquettes\u00a0: produits indications","author":"HAS","year":"2015"},{"issue":"11","key":"10.1016\/j.bulcan.2018.08.016_bib0170","doi-asserted-by":"crossref","first-page":"S193","DOI":"10.1016\/j.bulcan.2016.09.006","article-title":"How we harmonize HSCT clinical practices among the SFGM-TC centers","volume":"103","author":"Tipton","year":"2016","journal-title":"Bull Cancer"},{"issue":"8","key":"10.1016\/j.bulcan.2018.08.016_bib0175","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1111\/trf.14157","article-title":"Higgins. Determinants of red blood cell alloantibody detection duration: analysis of multiply alloimmunized patients supports peritransfusion factors","volume":"57","author":"Noiret","year":"2017","journal-title":"Transfusion"},{"key":"10.1016\/j.bulcan.2018.08.016_bib0180","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/vox.12419","article-title":"Transfusion-related alloimmunization in children: epidemiology and effects of chemotherapy","volume":"111","author":"Solh","year":"2016","journal-title":"Vox Sang"},{"key":"10.1016\/j.bulcan.2018.08.016_bib0185","series-title":"Isohaemagglutinin production after minor ABO incompatible umbilical cord blood transplantation","author":"British Blood Transfusion Society","year":"2017"},{"issue":"4","key":"10.1016\/j.bulcan.2018.08.016_bib0190","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.patbio.2014.05.007","article-title":"Impact of anti-HLA antibodies on outcomes of allogeneic stem cell transplantation: a report by the SFGM-TC","volume":"62","author":"Loiseau","year":"2014","journal-title":"Pathol Biol (Paris)"},{"key":"10.1016\/j.bulcan.2018.08.016_bib0195","doi-asserted-by":"crossref","first-page":"539825","DOI":"10.1155\/2012\/539825","article-title":"The presence of anti-HLA antibodies before and after allogeneic hematopoietic stem cells transplantation from HLA-mismatched unrelated donors","volume":"2012","author":"Koclega","year":"2012","journal-title":"Bone Marrow Res"},{"key":"10.1016\/j.bulcan.2018.08.016_bib0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/tan.12040","article-title":"On the role of HLA antibodies in hematopoietic stem cell transplantation","volume":"81","author":"Brand","year":"2013","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.bulcan.2018.08.016_bib0205","first-page":"961","article-title":"Principles of transfusion support before and after hematopoeitic cell transplantation","volume":"2-2","author":"McCullough","year":"2016"},{"issue":"9","key":"10.1016\/j.bulcan.2018.08.016_bib0210","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1111\/trf.14191","article-title":"Blood use in patients receiving intensive chemotherapy for acute leukemia or hematopoietic stem cell transplantation: the impact of a health system-wide patient blood management program","volume":"57","author":"Leahy","year":"2017","journal-title":"Transfusion"},{"key":"10.1016\/j.bulcan.2018.08.016_bib0215","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/bjh.14641","article-title":"Impact of red blood cell transfusion strategies in haemato-oncological patients: a systematic review and meta-analysis","volume":"178","author":"Marlijn","year":"2017","journal-title":"British J Haematol"},{"issue":"10","key":"10.1016\/j.bulcan.2018.08.016_bib0220","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1111\/trf.13767","article-title":"How I use clinical decision support to improve red blood cell utilization","volume":"56","author":"Tim Goodnough","year":"2016","journal-title":"Transfusion"},{"issue":"10","key":"10.1016\/j.bulcan.2018.08.016_bib0225","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1111\/trf.12723","article-title":"Restrictive blood transfusion practices are associated with improved patient outcomes","volume":"54","author":"Goodnough","year":"2014","journal-title":"Transfusion"},{"issue":"8","key":"10.1016\/j.bulcan.2018.08.016_bib0230","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1111\/trf.13075","article-title":"Implementation of a clinical decision support system improves compliance with restrictive transfusion policies in hematology patients","volume":"55","author":"Butler","year":"2015","journal-title":"Transfusion"},{"issue":"5","key":"10.1016\/j.bulcan.2018.08.016_bib0235","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1111\/trf.14083","article-title":"Encouraging single-unit transfusions: a superior patient blood management strategy","volume":"57","author":"Guinn","year":"2017","journal-title":"Transfusion"},{"issue":"5","key":"10.1016\/j.bulcan.2018.08.016_bib0240","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1111\/trf.14000","article-title":"Single-unit transfusions and hemoglobin trigger: relative impact on red cell utilization","volume":"57","author":"Yang","year":"2017","journal-title":"Transfusion"},{"issue":"3","key":"10.1016\/j.bulcan.2018.08.016_bib0245","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/bjh.14423","article-title":"Guidelines for the use of platelet transfusions","volume":"176","author":"Estcourt","year":"2017","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.bulcan.2018.08.016_bib0250","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/bjh.14750","article-title":"Platelet transfusions: are we ready to chill out?","volume":"178","author":"Ness","year":"2017","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.bulcan.2018.08.016_bib0255","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/vox.12489","article-title":"Patient outcomes and amotosalen\/UVA-treated platelet utilization in massively transfused patients","volume":"112","author":"Nussbaumer","year":"2017","journal-title":"Vox Sang"},{"issue":"26","key":"10.1016\/j.bulcan.2018.08.016_bib0260","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1182\/blood-2016-09-693655","article-title":"How I evaluate and treat thrombocytopenia in the intensive care unit patient","volume":"128","author":"Greinacher","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2018.08.016_bib0265","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/bjh.13597","article-title":"Platelet refractoriness \u2013 practical approaches and ongoing dilemmas in patient management","volume":"171","author":"Simon","year":"2015","journal-title":"Bristish J Haematol"},{"issue":"1","key":"10.1016\/j.bulcan.2018.08.016_bib0270","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/trf.14388","article-title":"Age of platelet concentrates and time to the next transfusion","volume":"58","author":"Caram-Deelder","year":"2018","journal-title":"Transfusion"},{"issue":"10","key":"10.1016\/j.bulcan.2018.08.016_bib0275","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1111\/trf.13738","article-title":"Optimal transfusion practices after allogeneic hematopoietic cell transplantation: a systematic scoping review of evidence from randomized controlled trials","volume":"56","author":"Christou","year":"2016","journal-title":"Transfusion"},{"key":"10.1016\/j.bulcan.2018.08.016_bib0280","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.tmrv.2016.06.002","article-title":"Complex transfusion issues in pediatric hematopoietic stem cell transplantation","volume":"30","author":"Webb","year":"2016","journal-title":"Transfus Med Rev"},{"issue":"2","key":"10.1016\/j.bulcan.2018.08.016_bib0285","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/trf.13353","article-title":"ABO blood group incompatibility as an adverse risk factor for outcomes in patients with myelodysplastic syndromes and acute myeloid leukemia undergoing HLA-matched peripheral blood hematopoietic cell transplantation after reduced-intensity conditioning","volume":"56","author":"Hefazi","year":"2016","journal-title":"Transfusion"},{"issue":"1","key":"10.1016\/j.bulcan.2018.08.016_bib0290","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.tracli.2007.03.008","article-title":"Consignes transfusionnelles en cas d\u2019allogreffe de cellules souches h\u00e9matopo\u00ef\u00e9tiques [Transfusion protocols in hematopoietic stem cell allogeneic transplantation]","volume":"14","author":"Bardiaux","year":"2007","journal-title":"Transfus Clin Biol"},{"issue":"2","key":"10.1016\/j.bulcan.2018.08.016_bib0295","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/trf.13876","article-title":"Red blood cell transfusion-transmitted acute hepatitis E in an immunocompetent subject in Europe: a case report","volume":"57","author":"Riveiro-Barciela","year":"2017","journal-title":"Transfusion"},{"key":"10.1016\/j.bulcan.2018.08.016_bib0300","series-title":"Logiciel m\u00e9dico-technique\u00a0: utilisation de la fiche d\u2019allogreffe","author":"Information ES","year":"2017"},{"issue":"2","key":"10.1016\/j.bulcan.2018.08.016_bib0305","first-page":"183","article-title":"Recommandations sur l\u2019utilisation de l\u2019\u00e9chographie lors de la mise en place des acc\u00e8s vasculaires","volume":"1","author":"Zetlaoui","year":"2015","journal-title":"Anesth Reanim"},{"issue":"10","key":"10.1016\/j.bulcan.2018.08.016_bib0155","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1111\/trf.14248","article-title":"Central venous catheter placement in coagulopathic patients: risk factors and incidence of bleeding complications","volume":"57","author":"van de Weerdt","year":"2017","journal-title":"Transfusion"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455118303047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455118303047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T19:30:16Z","timestamp":1757791816000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455118303047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0007455118303047"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2018.08.016","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transfusion dans l\u2019autogreffe et l\u2019allogreffe de cellules souches h\u00e9matopo\u00ef\u00e9tiques chez l\u2019adulte et l\u2019enfant\u00a0: recommandations de la Soci\u00e9t\u00e9 francophone de greffe de moelle et de th\u00e9rapie cellulaire (SFGM-TC)","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2018.08.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer.","name":"copyright","label":"Copyright"}]}}